Study at a glance
What was the question?
Do autoimmune tissues handle vitamin D differently, and could this explain disease risk? The review separates signals received by cells, genes involved in processing vitamin D, fluid concentrations and actual hormone production.
Who or what was studied?
Four investigations examined experimental arthritis in mice and joint cells, healthy human brain tissue, surgically collected thyroid tissue and blood with joint fluid from people with arthritis. They did not all study affected human organs directly.
What did the studies find?
A mouse and cell study found responses under controlled conditions. A healthy-brain study linked a risk-related genetic variant with the activity of a gene involved in vitamin D breakdown. Thyroid tissue showed higher expression of the vitamin D receptor, the protein that receives its signal. Differences in three genes involved in processing vitamin D were not statistically clear. Several vitamin D compounds were lower in rheumatoid joint fluid than blood.
What does this mean?
These findings do not establish that local metabolism caused human autoimmune disease. A gene measurement is not a direct measure of enzyme activity. Joint fluid is not the inside of a cell. An amount below the assay’s reliable range is not proof of zero production. The studies do not provide a personal supplement plan.
Read the full article below ↓Vitamin D findings inside an organ can look persuasive without showing what caused disease. Four investigations compared experimental joints, healthy brain tissue, surgically collected thyroid tissue and joint fluid. They measured different parts of vitamin D biology, so their results cannot be combined into one proven local disease mechanism. For the detailed analysis, read Local Vitamin D Metabolism and Autoimmune Tissues: Full Evidence Review.
Genes, receptors and concentrations answer different questions
A receptor receives a vitamin D signal. Enzymes help activate or break down vitamin D compounds. Measuring the RNA made from a gene does not directly measure an enzyme’s activity or the amount of active hormone produced. A fluid concentration is another measurement again: it reflects a compartment, not necessarily what happens inside a particular cell.
These distinctions matter when connecting organ biology to Vitamin D and Immune Tolerance. More receptor expression does not automatically mean better restraint of harmful immune responses. Nor does a lower fluid concentration establish why self-directed immunity developed.
What the four studies found
Gu and colleagues studied mice missing a vitamin D activation enzyme throughout the body, together with a rheumatoid joint-cell line exposed to active calcitriol. The experiments supported model-specific changes involving cell death and p53 signalling. Whole-body enzyme deletion does not isolate local joint metabolism, and supplying hormone to cultured cells does not demonstrate that those cells made it. A direction mismatch between Figure 3 prose and its image also requires careful interpretation. The full principal and supplementary material were assessed. [6]
Ramasamy and colleagues linked an MS-risk-associated variant with expression of the breakdown enzyme CYP24A1 in certain brain regions. The donors were healthy. This was not a measurement of active hormone or enzyme activity in affected MS lesions. The principal report and both supplements were assessed. Vitamin D Genetics explains why an inherited association need not predict an individual’s outcome or treatment response. [7]
Lim and colleagues found higher vitamin D receptor expression in thyroid tissue with Hashimoto’s thyroiditis. Differences in three metabolic enzymes were not statistically established. The tissue came from patients undergoing surgery for thyroid neoplasms, with small and differently composed assay subsets. Mixed cell populations and cross-sectional sampling prevent a conclusion about future disease risk. Sample-count, sex-composition and transcript-reporting inconsistencies further limit precision. The full report and supplement were assessed. [8]
Li and colleagues compared blood and joint fluid in active rheumatoid arthritis. Several metabolites were lower in joint fluid, with a D2 exception. Active hormone was below reliable quantification in many samples. This does not mean zero hormone or zero cellular production. There was no healthy joint-fluid comparison. The author manuscript and main figures were assessed; the final typeset paper and two supplements were not. Detailed free-hormone and disease-score claims are therefore excluded. [9]
What remains unresolved
These investigations show a response in experimental models, regional gene expression, an affected-thyroid receptor signature and a compartment difference. They do not establish that local metabolic changes caused human autoimmune disease. Each has a different relationship to the question, and the selected evidence does not include four direct tests of that causal claim.
Vitamin D and Immune Coordination: Cell Context, Timing and Clinical Limits: Full Evidence Review explains why cell environment and whole-organism outcomes need separate interpretation. Connecting plausible observations across different organs cannot replace the missing causal experiment. The studies do not establish a personal diagnosis, target blood concentration or supplement plan.
Scientific sources and access
Evidence assessed on 5 November 2026. This is an original synthesis of selected research, not a reproduction of the papers or a systematic review. Material source-access limits are identified in the analysis.
[6] Gu and colleagues. 1, 25-dihydroxy-vitamin D3 with tumor necrosis factor-alpha protects against rheumatoid arthritis by promoting p53 acetylation-mediated apoptosis via Sirt1 in synoviocytes. Cell death & disease. 2016 Oct 20;7(10):e2423. DOI: 10.1038/cddis.2016.300. PMID: 27763638.
[7] Ramasamy and colleagues. Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis. Multiple sclerosis and related disorders. 2014 Mar;3(2):211 to 219. DOI: 10.1016/j.msard.2013.08.009. PMID: 25568836.
[8] Lim and colleagues. Dysregulated vitamin D signaling in Hashimoto’s thyroiditis: an integrated transcriptomic study in a Korean cohort. Frontiers in endocrinology. 2025;16:1666115. DOI: 10.3389/fendo.2025.1666115. PMID: 41113708.
[9] Li and colleagues. Serum and synovial fluid vitamin D metabolites and rheumatoid arthritis. The Journal of steroid biochemistry and molecular biology. 2019 Mar;187:1 to 8. DOI: 10.1016/j.jsbmb.2018.10.008. PMID: 30611909.
Related reading
Local Vitamin D Metabolism and Autoimmune Tissues: Full Evidence Review
Compare joint, brain and thyroid research, separating receptor expression, enzyme activity and fluid measurements from autoimmune causation.
Read more →High frequency of vitamin D receptor gene polymorphism FokI in Brazilian Type 1 diabetes mellitus patients with clinical autoimmune thyroid disease
The aim of this study was to evaluate the relationship between VDR FokI polymorphism (rs10735810), thyroid autoimmunity and thyroid dysfunction (TD) in Brazilian T1DM.
Original paper ↗Read more →Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease
We aimed to investigate VDR binding in primary CD4+ cells from healthy volunteers.
Original paper ↗Read more →Vitamin D Receptor Gene Polymorphisms and Autoimmune Thyroiditis: Are They Associated with Disease Occurrence and Its Features?
Therefore, the study aimed to evaluate the association of these five VDR gene polymorphisms with susceptibility to autoimmune thyroiditis among Caucasian Polish population.
Original paper ↗Read more →In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling
This study aimed to investigate the interplay between the GR: and VitD receptor (VDR) signaling.
Original paper ↗Read more →Methylation of the Vitamin D Receptor Gene in Human Disorders
The Vitamin D Receptor (VDR) mediates the actions of 1,25-Dihydroxvitamin D3 (1,25(OH)2D3), which has important roles in bone homeostasis, growth/differentiation of cells, immune functions, and reduction of inflammation.
Original paper ↗Read more →Study of Vitamin D Level and Vitamin D Receptor Polymorphism in Hypothyroid Egyptian Patients
The current study aimed at assessing vitamin D level and vitamin D receptor polymorphism in hypothyroid Egyptian patients and its effect on hypothyroidism and thyroid morphology, also to find a causal relation between vitamin D and hypothyroidism.
Original paper ↗Read more →Vitamin D and VDR Gene Polymorphisms’ Association with Rheumatoid Arthritis in Lithuanian Population
Background and Objectives: Rheumatoid arthritis (RA) is a chronic, inflammatory, autoimmune, multi-factorial disease, in which environmental and genetic factors play a major role.
Original paper ↗Read more →Association of vitamin D receptor genetic variants with therapeutic response in multidrug-resistant pulmonary tuberculosis: a systematic review
In high-burden nations like India, tuberculosis (TB) continues to be a significant global public health concern.
Original paper ↗Read more →Association of vitamin D receptor mRNA expression, vitamin D deficiency and genetic variant in patients with multi-drug resistant pulmonary tuberculosis
To study the association of mRNA expression with low vitamin D levels and VDR polymorphisms in patients with MDR-TB compared to normal controls.
Original paper ↗Read more →Genetic variants of VDR and CYP2R1 affect BMI independently of serum vitamin D concentrations
Our objective was to investigate potential correlations between genetic variants in key enzymes of vitamin D metabolism and the body mass index on a representative and random sample of Hungarian adults.
Original paper ↗Read more →Influence of genetic variants of the vitamin D receptor on clinical profile in cirrhosis and hepatocellular carcinoma
The homozygous mutant for VDR-rs731236 and rs7975232 predominated in G1 compared to other groups (p < 0.05).
Original paper ↗Read more →Relevance of Serum Levels and Functional Genetic Variants in Vitamin D Receptor Gene among Saudi Women with Gestational Diabetes Mellitus
Haplotype analysis revealed positive associations among the examined SNPs, which seemed compatible with the hypothesis that variants and combinations of multiple SNP genotypes enhance the risk of GDM in women.
Original paper ↗Read more →Vitamin D Receptor (VDR) Genetic Variants: Relationship of FokI Genotypes with VDR Expression and Clinical Disease Activity in Systemic Lupus Erythematosus Patients
This study was aimed to determine the association of the VDR variants FokI (rs2228570), BsmI (rs1544410), ApaI (rs7975232), and TaqI (rs731236) with susceptibility to the disease, VD status, VDR mRNA expression, and clinical disease activity in SLE patients.
Original paper ↗Read more →Bone Tissue Evaluation Indicates Abnormal Mineralization in Patients with Autoimmune Polyendocrine Syndrome Type I: Report on Three Cases
Autoimmune polyendocrine syndrome type-1 (APS1) is characterized by autoimmune manifestations affecting different organs from early childhood on.
Original paper ↗Read more →Micronutrients in Autoimmune Diseases: Shining a Light on Vitamin D, Cobalamin, Folate, and Iron Metabolism
Autoimmune diseases (AIDs) are characterized by chronic inflammation and tissue damage resulting from abnormal immune responses.
Original paper ↗Read more →Vitamin D3 Metabolism and Its Role in Temporomandibular Joint Osteoarthritis and Autoimmune Thyroid Diseases
The aim of this review was to present the metabolism of vitamin D3, as well as to discuss the role of vitamin D3 in bone metabolism, temporomandibular joint osteoarthritis (TMJ OA), and autoimmune thyroid diseases (AITD) on the basis of the literature.
Original paper ↗Read more →Fat Mass Influences Femur Bone Strength and Geometry Parameters, but Not Bone Mineral Density, in Autoimmune Diabetes: A Pilot Study
This study examines how adiposity influences BMD and Dual X‐Ray Absorptiometry (DXA)‐derived parameters of bone geometry and strength in AD.
Original paper ↗Read more →Involvement of the Vitamin D Receptor in Energy Metabolism Revealed by Profiling of Lysine Succinylome of White Adipose Tissue
Lysine succinylation, emerging as a novel post-translational modification, is closely related to the regulation of diverse biological processes, including many aspects of metabolism.
Original paper ↗Read more →Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors
This study aimed to investigate the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors.
Original paper ↗Read more →Tissue-Specific VDR Pathway Gene Expression Is Not Associated with Circulating 25OHD in Adolescents with Severe Obesity
This study examined the expression patterns of VDR-target genes across metabolically diverse tissues and compared these molecular measures with circulating serum 25-hydroxyvitamin D (25OHD), the current clinical marker of vitamin D status.
Original paper ↗Read more →Original sources
1, 25-dihydroxy-vitamin D3 with tumor necrosis factor-alpha protects against rheumatoid arthritis by promoting p53 acetylation-mediated apoptosis via Sirt1 in synoviocytes
Published in Cell death & disease. 2016 Oct 20;7(10):e2423. DOI: 10.1038/cddis (2016).
Publication details
[6] Gu and colleagues. 1, 25-dihydroxy-vitamin D3 with tumor necrosis factor-alpha protects against rheumatoid arthritis by promoting p53 acetylation-mediated apoptosis via Sirt1 in synoviocytes. Cell death & disease. 2016 Oct 20;7(10):e2423. DOI: 10.1038/cddis.2016.300. PMID: 27763638.
Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis
Published in Multiple sclerosis and related disorders. 2014 Mar;3(2):211 to 219. DOI: 10.1016/j.msard (2013).
Publication details
[7] Ramasamy and colleagues. Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis. Multiple sclerosis and related disorders. 2014 Mar;3(2):211 to 219. DOI: 10.1016/j.msard.2013.08.009. PMID: 25568836.
Dysregulated vitamin D signaling in Hashimoto's thyroiditis: an integrated transcriptomic study in a Korean cohort
Published in Frontiers in endocrinology (2025).
Publication details
[8] Lim and colleagues. Dysregulated vitamin D signaling in Hashimoto’s thyroiditis: an integrated transcriptomic study in a Korean cohort. Frontiers in endocrinology. 2025;16:1666115. DOI: 10.3389/fendo.2025.1666115. PMID: 41113708.
Serum and synovial fluid vitamin D metabolites and rheumatoid arthritis
Published in The Journal of steroid biochemistry and molecular biology. 2019 Mar;187:1 to 8. DOI: 10.1016/j.jsbmb (2018).
Publication details
[9] Li and colleagues. Serum and synovial fluid vitamin D metabolites and rheumatoid arthritis. The Journal of steroid biochemistry and molecular biology. 2019 Mar;187:1 to 8. DOI: 10.1016/j.jsbmb.2018.10.008. PMID: 30611909.